Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/8/2014 |
| Start Date: | October 2013 |
| End Date: | October 2014 |
| Contact: | Carol Hardy, BS |
| Email: | chardy@harvardeye.com |
| Phone: | 949 900 5248 |
Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.
This study examines patient perceptions regarding the tolerability of two classes of
glaucoma medication: bimatoprost and latanoprost.
glaucoma medication: bimatoprost and latanoprost.
Patients enrolled in this study completed a validated survey instrument (COMTOL) examining
tolerability of topically applied ophthalmic medications that they are already taking in
their regular course of care for glaucoma. The purpose of the study is to determine whether
side effects and symptoms of the drugs already being taken cause problems with activities of
daily living.
tolerability of topically applied ophthalmic medications that they are already taking in
their regular course of care for glaucoma. The purpose of the study is to determine whether
side effects and symptoms of the drugs already being taken cause problems with activities of
daily living.
Inclusion Criteria:
- Patients with glaucoma taking either bimatoprost or latanoprost
Exclusion Criteria:
- patients taking other medication or with other causes for ocular surface symptoms
We found this trial at
1
site
Click here to add this to my saved trials
